 | | MSC | | Name: | 2,5-DIBENZYLOXY-3,4-DIHYDROXY-HEXANEDIOIC ACID 2-CHLORO-6-FLUORO-BENZYLAMIDE (2-HYDROXY-INDAN-1- YL)-AMIDE | | Formula: | C36 H36 Cl F N2 O7 | | SMILES: | Fc1cccc(Cl)c1CNC(=O)C(OCc2ccccc2)C(O)C(O)C(OCc3ccccc3)C(=O)NC5c4ccccc4CC5O | | InChi: | InChI=1S/C36H36ClFN2O7/c37-27-16-9-17-28(38)26(27)19-39-35(44)33(46-20-22-10-3-1-4-11-22)31(42)32(43)34(47-21-23-12-5-2-6-13-23)36(45)40-30-25-15-8-7-14-24(25)18-29(30)41/h1-17,29-34,41-43H,18-21H2,(H,39,44)(H,40,45)/t29-,30+,31-,32-,33-,34-/m1/s1 | | Synonyms: | INHIBITOR MSL370 | | Definition date: | 1999-10-05 | | Last modified: | 2021-03-01 | | Identifier: | (2R,3R,4R,5R)-2,5-bis(benzyloxy)-N-(2-chloro-6-fluorobenzyl)-3,4-dihydroxy-N'-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]hexanediamide (non-preferred name) |
|
 | | MSL | | Name: | (2S)-2-AMINO-4-(METHYLSULFONIMIDOYL)BUTANOIC ACID | | Formula: | C5 H12 N2 O3 S | | SMILES: | O=S(=N)(C)CCC(C(=O)O)N | | InChi: | InChI=1S/C5H12N2O3S/c1-11(7,10)3-2-4(6)5(8)9/h4,7H,2-3,6H2,1H3,(H,8,9)/t4-,11-/m0/s1 | | Synonyms: | METHIONINE SULFOXIMINE | | Definition date: | 2005-09-27 | | Last modified: | 2021-03-01 | | Identifier: | (2S)-2-amino-4-(S-methylsulfonimidoyl)butanoic acid |
|
 | | MSZ | | Name: | (2S)-(4-chlorophenyl)[3-(trifluoromethyl)phenoxy]ethanoic acid | | Formula: | C15 H10 Cl F3 O3 | | SMILES: | Clc1ccc(cc1)C(Oc2cc(ccc2)C(F)(F)F)C(=O)O | | InChi: | InChI=1S/C15H10ClF3O3/c16-11-6-4-9(5-7-11)13(14(20)21)22-12-3-1-2-10(8-12)15(17,18)19/h1-8,13H,(H,20,21)/t13-/m0/s1 | | Synonyms: | Metaglidasen (S enantiomer) | | Definition date: | 2014-04-09 | | Last modified: | 2021-03-01 | | Release date: | 2015-02-11 | | Identifier: | (2S)-(4-chlorophenyl)[3-(trifluoromethyl)phenoxy]ethanoic acid |
|
 | | MT1 | | Name: | N-(4-{[(2,4-DIAMINOPTERIDIN-1-IUM-6-YL)METHYL](METHYL)AMINO}BENZOYL)-L-GLUTAMIC ACID | | Formula: | C20 H23 N8 O5 | | SMILES: | O=C(O)C(NC(=O)c1ccc(cc1)N(C)Cc2nc3c(nc2)[nH+]c(nc3N)N)CCC(=O)O | | InChi: | InChI=1S/C20H22N8O5/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27)/p+1/t13-/m0/s1 | | Synonyms: | METHOTREXATE PROTONATED AT N1 | | Definition date: | 2006-10-25 | | Last modified: | 2021-03-01 | | Identifier: | N-[(4-{[(2,4-diaminopteridin-1-ium-6-yl)methyl](methyl)amino}phenyl)carbonyl]-L-glutamic acid |
|
 | | MT9 | | Name: | (3R,4S,5S,7R,9E,11S,12R)-12-ethyl-11-hydroxy-3,5,7,11-tetramethyl-2,8-dioxooxacyclododec-9-en-4-yl 3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranoside | | Formula: | C25 H43 N O7 | | SMILES: | O=C2OC(CC)C(O)(C=CC(=O)C(C)CC(C(OC1OC(CC(N(C)C)C1O)C)C2C)C)C | | InChi: | InChI=1S/C25H43NO7/c1-9-20-25(6,30)11-10-19(27)14(2)12-15(3)22(17(5)23(29)32-20)33-24-21(28)18(26(7)8)13-16(4)31-24/h10-11,14-18,20-22,24,28,30H,9,12-13H2,1-8H3/b11-10+/t14-,15+,16-,17-,18+,20-,21-,22+,24+,25+/m1/s1 | | Synonyms: | methymycin | | Definition date: | 2009-04-22 | | Last modified: | 2021-03-01 | | Identifier: | (3R,4S,5S,7R,9E,11S,12R)-12-ethyl-11-hydroxy-3,5,7,11-tetramethyl-2,8-dioxooxacyclododec-9-en-4-yl 3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranoside |
|
 | | MTH | | Name: | 2-(4-AMINO-PYRROLO[2,3-D]PYRIMIDIN-7-YL)-5-METHYLSULFANYLMETHYL-TETRAHYDRO-FURAN-3,4-DIOL | | Formula: | C12 H16 N4 O3 S | | SMILES: | S(C)CC3OC(n2ccc1c(ncnc12)N)C(O)C3O | | InChi: | InChI=1S/C12H16N4O3S/c1-20-4-7-8(17)9(18)12(19-7)16-3-2-6-10(13)14-5-15-11(6)16/h2-3,5,7-9,12,17-18H,4H2,1H3,(H2,13,14,15)/t7-,8-,9-,12-/m1/s1 | | Synonyms: | 5'-DEOXY-5'-(METHYLTHIO)-TUBERCIDIN | | Definition date: | 2002-12-12 | | Last modified: | 2021-03-01 | | Identifier: | 7-(5-S-methyl-5-thio-beta-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
|
 | | MTN | | Name: | S-[(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate | | Formula: | C10 H18 N O3 S2 | | SMILES: | ON1C(C=C(CSS(=O)(=O)C)C1(C)C)(C)C | | InChi: | InChI=1S/C10H19NO3S2/c1-9(2)6-8(7-15-16(5,13)14)10(3,4)11(9)12/h6,12H,7H2,1-5H3 | | Synonyms: | MTSL | | Definition date: | 2003-12-10 | | Last modified: | 2021-03-01 | | Identifier: | S-[(1-hydroxy-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate |
|
 | | MTP | | Name: | 2-HYDROXYMETHYL-5-(6-METHYLSULFANYL-PURIN-9-YL)-TETRAHYDRO-FURAN-3,4-DIOL | | Formula: | C11 H14 N4 O4 S | | SMILES: | n2c1c(ncnc1SC)n(c2)C3OC(C(O)C3O)CO | | InChi: | InChI=1S/C11H14N4O4S/c1-20-10-6-9(12-3-13-10)15(4-14-6)11-8(18)7(17)5(2-16)19-11/h3-5,7-8,11,16-18H,2H2,1H3/t5-,7-,8-,11-/m1/s1 | | Synonyms: | 9-BETA-D-RIBOFURANOSYL-6-METHYLTHIOPURINE | | Definition date: | 2003-06-23 | | Last modified: | 2021-03-01 | | Identifier: | 6-(methylsulfanyl)-9-beta-D-ribofuranosyl-9H-purine |
|
 | | MUC | | Name: | [(2S)-5-oxo-2,5-dihydrofuran-2-yl]acetic acid | | Formula: | C6 H6 O4 | | SMILES: | O=C(O)CC1OC(=O)C=C1 | | InChi: | InChI=1S/C6H6O4/c7-5(8)3-4-1-2-6(9)10-4/h1-2,4H,3H2,(H,7,8)/t4-/m1/s1 | | Synonyms: | muconolactone | | Definition date: | 2008-06-15 | | Last modified: | 2021-03-01 | | Identifier: | [(2S)-5-oxo-2,5-dihydrofuran-2-yl]acetic acid |
|
 | | MUS | | Name: | 4-METHYL-2-OXO-2H-CHROMEN-7-YL 5-(ACETYLAMINO)-3,5-DIDEOXY-L-ERYTHRO-NON-2-ULOPYRANOSIDONIC ACID | | Formula: | C21 H25 N O11 | | SMILES: | O=C3Oc2c(ccc(OC1(OC(C(O)C(O)CO)C(NC(=O)C)C(O)C1)C(=O)O)c2)C(=C3)C | | InChi: | InChI=1S/C21H25NO11/c1-9-5-16(27)31-15-6-11(3-4-12(9)15)32-21(20(29)30)7-13(25)17(22-10(2)24)19(33-21)18(28)14(26)8-23/h3-6,13-14,17-19,23,25-26,28H,7-8H2,1-2H3,(H,22,24)(H,29,30)/t13-,14+,17+,18+,19+,21+/m0/s1 | | Synonyms: | METHYLUMBELLIFERYL SIALIC ACID | | Definition date: | 2004-01-19 | | Last modified: | 2021-03-01 | | Identifier: | 4-methyl-2-oxo-2H-chromen-7-yl 5-(acetylamino)-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosidonic acid |
|
 | | MVC | | Name: | MONOVACCENIN | | Formula: | C21 H40 O4 | | SMILES: | O=C(OCC(O)CO)CCCCCCCCCC=C/CCCCCC | | InChi: | InChI=1S/C21H40O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-21(24)25-19-20(23)18-22/h7-8,20,22-23H,2-6,9-19H2,1H3/b8-7-/t20-/m1/s1 | | Synonyms: | 11.7 MAG | | Definition date: | 2011-06-08 | | Last modified: | 2021-03-01 | | Identifier: | (2R)-2,3-dihydroxypropyl (11Z)-octadec-11-enoate |
|
 | | MWB | | Name: | N1-(4,5-dihydro-1H-imidazol-2-yl)-N4-(4-((4,5-dihydro-1H-imidazol-2-yl)amino)phenyl)benzene-1,4-diamine | | Formula: | C18 H21 N7 | | SMILES: | N4=C(Nc3ccc(Nc2ccc(NC1=NCCN1)cc2)cc3)NCC4 | | InChi: | InChI=1S/C18H21N7/c1-5-15(24-17-19-9-10-20-17)6-2-13(1)23-14-3-7-16(8-4-14)25-18-21-11-12-22-18/h1-8,23H,9-12H2,(H2,19,20,24)(H2,21,22,25) | | Synonyms: | CD27 | | Definition date: | 2014-02-04 | | Last modified: | 2021-03-01 | | Release date: | 2014-06-11 | | Identifier: | N-(4,5-dihydro-1H-imidazol-2-yl)-N'-[4-(4,5-dihydro-1H-imidazol-2-ylamino)phenyl]benzene-1,4-diamine |
|
 | | MX7 | | Name: | (2R)-3-(phosphonooxy)propane-1,2-diyl (9Z,9'Z)bis-octadec-9-enoate | | Formula: | C39 H73 O8 P | | SMILES: | O=C(OC(COP(=O)(O)O)COC(=O)CCCCCCCC=C/CCCCCCCC)CCCCCCCC=C/CCCCCCCC | | InChi: | InChI=1S/C39H73O8P/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-38(40)45-35-37(36-46-48(42,43)44)47-39(41)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h17-20,37H,3-16,21-36H2,1-2H3,(H2,42,43,44)/b19-17-,20-18-/t37-/m1/s1 | | Synonyms: | dioleoyl-phosphatidic acid | | Definition date: | 2013-09-30 | | Last modified: | 2021-03-01 | | Release date: | 2014-10-01 | | Identifier: | (2R)-3-(phosphonooxy)propane-1,2-diyl (9Z,9'Z)bis-octadec-9-enoate |
|
 | | MXL | | Name: | MOXALACTAM | | Formula: | C20 H20 N6 O9 S | | SMILES: | O=C2N1C(=C(COC1C2(OC)NC(=O)C(c3ccc(O)cc3)C(=O)O)CSc4nnnn4C)C(=O)O | | InChi: | InChI=1S/C20H20N6O9S/c1-25-19(22-23-24-25)36-8-10-7-35-18-20(34-2,17(33)26(18)13(10)16(31)32)21-14(28)12(15(29)30)9-3-5-11(27)6-4-9/h3-6,12,18,27H,7-8H2,1-2H3,(H,21,28)(H,29,30)(H,31,32)/t12-,18-,20+/m1/s1 | | Synonyms: | 7-((CARBOXY(4-HYDROXYPHENYL)ACETYL)AMINO)-7-METHOXY-(3-((1-METHYL-1H-TETRAZOL-5-YL)THIO)METHYL)-8-OXO-5-OXA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLIC ACID | | Definition date: | 2001-10-30 | | Last modified: | 2021-03-01 | | Identifier: | (6R,7R)-7-{[(2R)-2-carboxy-2-(4-hydroxyphenyl)acetyl]amino}-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
|
 | | MXR | | Name: | (2S,3R,4S)-4-{[(3S,5R)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-2-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-3-methyl-3,4-dihydro-2H-pyrrole-5-carboxylic acid | | Formula: | C17 H27 N3 O5 S | | SMILES: | O=C(O)C2=NC(C(C2SC1CC(C(=O)N(C)C)NC1)C)C(C=O)C(O)C | | InChi: | InChI=1S/C17H27N3O5S/c1-8-13(11(7-21)9(2)22)19-14(17(24)25)15(8)26-10-5-12(18-6-10)16(23)20(3)4/h7-13,15,18,22H,5-6H2,1-4H3,(H,24,25)/t8-,9-,10+,11-,12-,13-,15+/m1/s1 | | Synonyms: | meropenem bound form (tautomerism) | | Definition date: | 2012-10-02 | | Last modified: | 2021-03-01 | | Release date: | 2013-06-19 | | Identifier: | (2S,3R,4S)-4-{[(3S,5R)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-2-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-3-methyl-3,4-dihydro-2H-pyrrole-5-carboxylic acid |
|
 | | MYK | | Name: | N~6~-tetradecanoyl-L-lysine | | Formula: | C20 H40 N2 O3 | | SMILES: | O=C(O)C(N)CCCCNC(=O)CCCCCCCCCCCCC | | InChi: | InChI=1S/C20H40N2O3/c1-2-3-4-5-6-7-8-9-10-11-12-16-19(23)22-17-14-13-15-18(21)20(24)25/h18H,2-17,21H2,1H3,(H,22,23)(H,24,25)/t18-/m0/s1 | | Synonyms: | N6-myristoyl lysine | | Definition date: | 2011-10-17 | | Last modified: | 2021-03-01 | | Identifier: | N~6~-tetradecanoyl-L-lysine |
|
 | | MYQ | | Name: | (S)-(1,2-DICARBOXYETHYLTHIO)GOLD | | Formula: | C4 H5 Au O4 S | | SMILES: | O=C(O)CC(S[Au])C(=O)O | | InChi: | InChI=1S/C4H6O4S.Au/c5-3(6)1-2(9)4(7)8 | | Synonyms: | MYOCRISIN | | Definition date: | 2005-09-07 | | Last modified: | 2021-03-01 | | Identifier: | gold(1+) (1S)-1,2-dicarboxyethanethiolate |
|
 | | MYZ | | Name: | Myristoleic acid | | Formula: | C14 H26 O2 | | SMILES: | O=C(O)CCCCCCCC=C/CCCC | | InChi: | InChI=1S/C14H26O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14(15)16/h5-6H,2-4,7-13H2,1H3,(H,15,16)/b6-5- | | Synonyms: | Z-tetradec-9-enoic acid | | Definition date: | 2014-09-05 | | Last modified: | 2021-03-01 | | Release date: | 2015-02-25 | | Identifier: | (9Z)-tetradec-9-enoic acid |
|
 | | MZB | | Name: | (1R,2R,3R,4S,5R)-4-amino-5-[(R)-methylsulfinyl]cyclopentane-1,2,3-triol | | Formula: | C6 H13 N O4 S | | SMILES: | O=S(C1C(O)C(O)C(O)C1N)C | | InChi: | InChI=1S/C6H13NO4S/c1-12(11)6-2(7)3(8)4(9)5(6)10/h2-6,8-10H,7H2,1H3/t2-,3+,4+,5+,6+,12+/m0/s1 | | Synonyms: | MANNOSTATIN B | | Definition date: | 2008-07-25 | | Last modified: | 2021-03-01 | | Identifier: | (1R,2R,3R,4S,5R)-4-amino-5-[(R)-methylsulfinyl]cyclopentane-1,2,3-triol |
|
 | | MZM | | Name: | N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2(3H)-ylidene)acetamide | | Formula: | C5 H8 N4 O3 S2 | | SMILES: | NS(=O)(=O)C=1S/C(N(N=1)C)=NC(=O)C | | InChi: | InChI=1S/C5H8N4O3S2/c1-3(10)7-4-9(2)8-5(13-4)14(6,11)12/h1-2H3,(H2,6,11,12)/b7-4- | | Synonyms: | Methazolamide | | Definition date: | 1999-07-08 | | Last modified: | 2021-03-01 | | Identifier: | N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2(3H)-ylidene)acetamide |
|
 | | N02 | | Name: | (1S,2S)-2-{[N-({[1-(tert-butoxycarbonyl)-4-ethylpiperidin-4-yl]oxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid | | Formula: | C26 H46 N4 O10 S | | SMILES: | C(=O)(NC(C(=O)NC(C(O)S(=O)(=O)O)CC1CCNC1=O)CC(C)C)OC2(CCN(CC2)C(=O)OC(C)(C)C)CC | | InChi: | InChI=1S/C26H46N4O10S/c1-7-26(9-12-30(13-10-26)24(35)40-25(4,5)6)39-23(34)29-18(14-16(2)3)21(32)28-19(22(33)41(36,37)38)15-17-8-11-27-20(17)31/h16-19,22,33H,7-15H2,1-6H3,(H,27,31)(H,28,32)(H,29,34)(H,36,37,38)/t17-,18-,19-,22-/m0/s1 | | Synonyms: | bound form | | Definition date: | 2017-07-28 | | Last modified: | 2021-03-01 | | Release date: | 2018-04-04 | | Identifier: | (1S,2S)-2-{[N-({[1-(tert-butoxycarbonyl)-4-ethylpiperidin-4-yl]oxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid |
|
 | | N0G | | Name: | 2-{(Z)-[(2-hydroxynaphthalen-1-yl)methylidene]amino}-N-[(1S)-1-phenylethyl]benzamide | | Formula: | C26 H22 N2 O2 | | SMILES: | N(/c2c(C(=O)NC(c1ccccc1)C)cccc2)=C/c4c3c(cccc3)ccc4O | | InChi: | InChI=1S/C26H22N2O2/c1-18(19-9-3-2-4-10-19)28-26(30)22-13-7-8-14-24(22)27-17-23-21-12-6-5-11-20(21)15-16-25(23)29/h2-18,29H,1H3,(H,28,30)/b27-17-/t18-/m0/s1 | | Synonyms: | Sirtinol | | Definition date: | 2019-04-26 | | Last modified: | 2021-03-01 | | Release date: | 2020-06-24 | | Identifier: | 2-{(Z)-[(2-hydroxynaphthalen-1-yl)methylidene]amino}-N-[(1S)-1-phenylethyl]benzamide |
|
 | | N2F | | Name: | 2-[(4-methylphenyl)sulfonyl]-5-nitrofuran | | Formula: | C11 H9 N O5 S | | SMILES: | O=[N+]([O-])c1oc(cc1)S(=O)(=O)c2ccc(cc2)C | | InChi: | InChI=1S/C11H9NO5S/c1-8-2-4-9(5-3-8)18(15,16)11-7-6-10(17-11)12(13)14/h2-7H,1H3 | | Synonyms: | NSC697923 | | Definition date: | 2014-02-07 | | Last modified: | 2021-03-01 | | Release date: | 2015-05-06 | | Identifier: | 2-[(4-methylphenyl)sulfonyl]-5-nitrofuran |
|
 | | N2H | | Name: | (4-azanylbutylamino)methanediol | | Formula: | C5 H14 N2 O2 | | SMILES: | NCCCCNC(O)O | | InChi: | InChI=1S/C5H14N2O2/c6-3-1-2-4-7-5(8)9/h5,7-9H,1-4,6H2 | | Synonyms: | N-(dihydroxymethyl)putrescine | | Definition date: | 2015-12-31 | | Last modified: | 2021-03-01 | | Release date: | 2016-04-20 | | Identifier: | (4-azanylbutylamino)methanediol |
|
 | | N32 | | Name: | 2,4-dihydroxy-3-({3-[(2S,4aS,8S,8aR)-8-methyl-3-methylidene-7-oxo-1,3,4,7,8,8a-hexahydro-2H-2,4a-ethanonaphthalen-8-yl]propanoyl}amino)benzoic acid | | Formula: | C24 H27 N O6 | | SMILES: | O=C(O)c1c(O)c(c(O)cc1)NC(=O)CCC3(C(=O)C=CC42CCC(/C(=C)C2)CC34)C | | InChi: | InChI=1S/C24H27NO6/c1-13-12-24-9-5-14(13)11-17(24)23(2,18(27)6-10-24)8-7-19(28)25-20-16(26)4-3-15(21(20)29)22(30)31/h3-4,6,10,14,17,26,29H,1,5,7-9,11-12H2,2H3,(H,25,28)(H,30,31)/t14-,17-,23-,24+/m0/s1 | | Synonyms: | Platencin | | Definition date: | 2009-06-02 | | Last modified: | 2021-03-01 | | Identifier: | 2,4-dihydroxy-3-({3-[(2S,4aS,8S,8aR)-8-methyl-3-methylidene-7-oxo-1,3,4,7,8,8a-hexahydro-2H-2,4a-ethanonaphthalen-8-yl]propanoyl}amino)benzoic acid |
|
